SHANXI KANGBAO · COMPANY INFORMATION
Business capabilities
Explore documented biological-product and pharmaceutical-preparation scopes, alongside the independently operated HealthyWelness research catalog.
Explore the company’s documented business context alongside the separately operated research catalog. A capability statement is useful only when its entity, site, material and date remain clear.
Plasma-derived biological products
Published entries in the national biological-product batch-release portal identify Shanxi Kangbao as marketing authorisation holder for specific human albumin, factor VIII, prothrombin complex and fibrinogen lots. These records demonstrate the listed regulatory release events; they are not a general test certificate for every product associated with the company.
Open the dated public records ↗
Pharmaceutical preparations
The official historical licence archive published in December 2023 lists manufacturing scope at two Changzhi-area addresses, including APIs, small-volume injections, lyophilised powder injections and several oral dosage forms, as well as biological-product categories. The entry records an issue date of 5 September 2023 and an expiry date of 20 December 2025.
A commercial database now reports a later issue date and expiry. The current original licence and its complete annex should be checked before treating that later scope as confirmed. A historical or third-party entry must not be presented as a current certificate issued by this website.
Peptide-related development: read the exact scope
The 2023 historical archive includes a recombinant thymosin alpha-1 entry among the described biological-product scopes. This is relevant to understanding the company’s recorded history. It does not establish current approval, commercial availability, chemical solid-phase peptide synthesis capacity, or the origin of tirzepatide, TB-500 or any other product in the research shop.
Likewise, protein-separation experience does not by itself validate a particular synthetic-peptide purification method. A patent describes a disclosed invention; production-scale use and performance need their own evidence.
The HealthyWelness research collection
The research catalog is independently sourced and operated by HealthyWelness. It brings together peptides and related laboratory materials. It is not a list of medicines manufactured or authorised by Kangbao.
Product pages retain their specifications, available sizes, prices, ordering tools and links to available documentation. Before ordering, confirm the exact material, pack, lot and report availability. Some products may have no published lot report; absence of a report is not a passed test.
What to discuss for a supply project
| Project question | Information to establish |
|---|---|
| What material is required? | Exact identity, intended research scope, specification and quantity |
| Who will make or supply it? | Named parties and a documented product-specific supply arrangement |
| What evidence is available? | Current relevant permissions, lot identity and the actual reports held |
| What can be disclosed? | Company permission for names, photographs, documents and the stated relationship |
| Can it be supplied to the destination? | Project-specific commercial and destination requirements |
Use the Contact page to describe a project. The current company presentation does not promise a manufacturing service, regulatory approval or export eligibility for an unspecified product.
Information reviewed against the cited sources on 15 November 2026. A published record applies to the named entity, product and date; it is not a general certification of the research catalog.